$RVNC Revance Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Revance Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Revance Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Revance Therapeutics, Inc. for free.
IRS Number: 770551645
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: RVNC
Company Address: 1222 DEMONBREUN STREET SUITE 1001 NASHVILLE 37203
Phone number: 510-742-3400
Former name: Essential Biosystems, Inc.
Former name: Essentia Biosystems, Inc.
Market Capitalization: $591.69M
Prev close: $20.70
Average Daily Volume: 183,115
Days Low: $20.40
Year Low: $12.35
Year High: $24.30
Revance Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | RVNC | Revance Therapeuti ... | Ware Olivia C | Director | Option Exercise | A | 27.91 | 1,268 | 35,390 | 1,268 | |
| May 07 2021 | RVNC | Revance Therapeuti ... | Ware Olivia C | Director | Grant | A | 0.00 | 674 | 0 | 7,082 | 6.4 K to 7.1 K (+10.52 %) |
| May 07 2021 | RVNC | Revance Therapeuti ... | Vickers Philip J. | Director | Option Exercise | A | 27.91 | 7,551 | 210,748 | 7,551 | |
| May 07 2021 | RVNC | Revance Therapeuti ... | Vickers Philip J. | Director | Grant | A | 0.00 | 4,013 | 0 | 23,663 | 19.7 K to 23.7 K (+20.42 %) |
| May 07 2021 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Option Exercise | A | 27.91 | 7,551 | 210,748 | 7,551 | |
| May 07 2021 | RVNC | Revance Therapeuti ... | Russell Angus C. | Director | Grant | A | 0.00 | 4,013 | 0 | 20,513 | 16.5 K to 20.5 K (+24.32 %) |
| May 07 2021 | RVNC | Revance Therapeuti ... | Nolet Chris | Director | Option Exercise | A | 27.91 | 7,551 | 210,748 | 7,551 | |
| May 07 2021 | RVNC | Revance Therapeuti ... | Nolet Chris | Director | Grant | A | 0.00 | 4,013 | 0 | 19,013 | 15 K to 19 K (+26.75 %) |
| May 07 2021 | RVNC | Revance Therapeuti ... | Kolaja Carey OConnor | Director | Option Exercise | A | 27.91 | 1,268 | 35,390 | 1,268 | |
| May 07 2021 | RVNC | Revance Therapeuti ... | Kolaja Carey OConnor | Director | Grant | A | 0.00 | 674 | 0 | 6,968 | 6.3 K to 7 K (+10.71 %) |
| May 07 2021 | RVNC | Revance Therapeuti ... | Gangolli Julian S | Director | Option Exercise | A | 27.91 | 7,551 | 210,748 | 7,551 | |
| May 07 2021 | RVNC | Revance Therapeuti ... | Gangolli Julian S | Director | Grant | A | 0.00 | 4,013 | 0 | 20,513 | 16.5 K to 20.5 K (+24.32 %) |
| May 07 2021 | RVNC | Revance Therapeuti ... | Beraud Jill | Director | Option Exercise | A | 27.91 | 7,551 | 210,748 | 7,551 | |
| May 07 2021 | RVNC | Revance Therapeuti ... | Beraud Jill | Director | Grant | A | 0.00 | 4,013 | 0 | 19,013 | 15 K to 19 K (+26.75 %) |
| Apr 16 2021 | RVNC | Revance Therapeuti ... | Sjuts Dustin S | Chief Commercial Of ... | Payment of Exercise | F | 28.16 | 411 | 11,574 | 65,098 | 65.5 K to 65.1 K (-0.63 %) |